BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8254521)

  • 1. The neuropeptide CRF is involved in the modulation of the baroreflex during hindlimb ischaemia in the anaesthetized rat.
    Turnbull AV; Kirkman E; Rothwell NJ; Little RA
    J Physiol; 1993 Aug; 468():529-41. PubMed ID: 8254521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the corticoliberin fragment CRF(4-6) on blood pressure and heart rate in rats].
    Makarenko EIu; Andreeva LA; Borovik AS; Mart'ianov AA
    Ross Fiziol Zh Im I M Sechenova; 2005 Jan; 91(1):71-9. PubMed ID: 15773582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
    Diamant M; de Wied D
    Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The central role of corticotrophin-releasing factor (CRF-41) in psychological stress in rats.
    Morimoto A; Nakamori T; Morimoto K; Tan N; Murakami N
    J Physiol; 1993 Jan; 460():221-9. PubMed ID: 8487193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular responses to exercise in the rat: role of corticotropin-releasing factor.
    Kregel KC; Overton JM; Seals DR; Tipton CM; Fisher LA
    J Appl Physiol (1985); 1990 Feb; 68(2):561-7. PubMed ID: 2318769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular activation by serotonergic stimulation: role of corticotropin-releasing factor.
    Dedeoğlu A; Fisher LA
    Am J Physiol; 1994 Sep; 267(3 Pt 2):R859-64. PubMed ID: 8092332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
    Diamant M; Kashtanov SI; Fodor M; de Wied D
    Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated restraint stress-induced increase in baroreceptor reflex sensitivity: role of corticotropin-releasing factor.
    Conti LH; Shannon MH; Murry JD; Printz MP
    Neuropeptides; 2001 Apr; 35(2):71-81. PubMed ID: 11384202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of corticotropin releasing factor-induced hypotension in anesthetized rats with the CRF antagonist, alpha-helical CRF9-41; comparison with effect on ACTH release.
    Corder R; Turnill D; Ling N; Gaillard RC
    Peptides; 1992; 13(1):1-6. PubMed ID: 1320258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic corticotrophin-releasing factor and norepinephrine mediate sympathetic and cardiovascular responses to acute intracarotid injection of tumour necrosis factor-alpha in the rat.
    Zhang ZH; Felder RB
    J Neuroendocrinol; 2008 Aug; 20(8):978-87. PubMed ID: 18777604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRF
    Oliveira LA; Almeida J; Gomes-de-Souza L; Benini R; Crestani CC
    Eur J Neurosci; 2017 Jul; 46(2):1805-1812. PubMed ID: 28612996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of the midbrain periaqueductal grey in the cardiovascular response to injury in the conscious and anaesthetized rat.
    Jones RO; Kirkman E; Little RA
    Exp Physiol; 1990 Jul; 75(4):483-95. PubMed ID: 2223051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of naloxone on the cardiovascular and respiratory effects of centrally administered corticotrophin releasing factor in conscious rabbits.
    May CN; Whitehead CJ; Mathias CJ
    Br J Pharmacol; 1991 Jul; 103(3):1776-80. PubMed ID: 1933140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats.
    Diamant M; de Wied D
    Endocrinology; 1991 Jul; 129(1):446-54. PubMed ID: 2055199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular injection of stresscopin-related peptide enhances cardiovascular function in conscious rats.
    Jin R; Li MZ; Bing YH; Piao RL; Li YJ; Jin QH; Qiu DL; Kannan H; Chu CP
    Regul Pept; 2013 Sep; 186():7-11. PubMed ID: 23850799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain.
    Strijbos PJ; Relton JK; Rothwell NJ
    Brain Res; 1994 Sep; 656(2):405-8. PubMed ID: 7820601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury.
    Lyons MK; Anderson RE; Meyer FB
    Brain Res; 1991 Apr; 545(1-2):339-42. PubMed ID: 1860056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats.
    Overton JM; Fisher LA
    J Auton Nerv Syst; 1991 Jul; 35(1):43-51. PubMed ID: 1940026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
    Fisher L; Rivier C; Rivier J; Brown M
    Endocrinology; 1991 Sep; 129(3):1312-6. PubMed ID: 1651845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin releasing factor and substance P mediate the nucleus amygdaloideus centralis-nucleus ventromedialis-nucleus dorsomedialis pressor system.
    Wu JS; Ku YH; Li LS; Lu YC; Ding X; Wang YG
    Brain Res; 1999 Sep; 842(2):392-8. PubMed ID: 10526135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.